Stocktoria

Iterum Therapeutics plc ITRMF

OTC · stock · Pharmaceutical Preparations · website · IPO 2018-05-25

Iterum Therapeutics plc statistics & valuation

Market cap$2.6M
Net debt$7.1M
Enterprise value USD$9.7M
Earnings yield EBIT/EV-192.1%
Return on capital-69.3%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20172018201920202021202220232024
Operating margin (%)
-5798.20% -8810.00% -275732.40% 20172018201920202021202220232024
Return on equity (%)
-74.50% -107.60% -182.30% -158.70% 20172018201920202021202220232024
Shares outstanding
1.6M 10.9M 12.2M 13.0M 19.7M 20172018201920202021202220232024
Net debt ($)
-$8.5M -$31.5M $2.8M $8.0M -$20.5M -$8.4M $5.4M $7.1M 20172018201920202021202220232024
Share buybacks ($)
20172018201920202021202220232024
Return on assets (%)
-62.90% -78.70% -400.50% -158.60% -100.10% -66.50% -146.10% -55.60% 20172018201920202021202220232024
Free cash flow margin (%)
-6184.30% -8900.10% -221475.70% 20172018201920202021202220232024
Debt / equity (×)
0.00× 0.18× 0.14× 0.45× 20172018201920202021202220232024
EPS ($)
-$32.49 -$8.41 -$3.63 -$2.96 -$1.26 20172018201920202021202220232024

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin—————-275732.4%-8810.0%-5798.2%
Net margin—————-278729.7%-8867.2%-5788.6%
FCF margin—————-221475.7%-8900.1%-6184.3%
Return on assets-55.6%-146.1%-66.5%-100.1%-158.6%-400.5%-78.7%-62.9%
Return on equity607.1%599.3%-158.7%-182.3%102.9%393.1%-107.6%-74.5%
Debt / equity-7.65×-1.79×0.45×0.14×-0.44×-0.29×0.18×0.00×
Current ratio1.411.896.896.430.510.327.616.20

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.